高血圧治療のための固定用量配合錠:レゴ®アーキテクチャに着想を得たモジュラーデザイン
Tanikan Sangnim1, Kittipat Suwanpitak1, Pornsak Sriamornsak2
1Faculty of Pharmaceutical Sciences, Burapha University, Chonburi, 20131, Thailand.
まとめ
本研究では、高血圧治療のためのカスタマイズ可能な固定用量配合(FDC)錠を作成するための、レゴ®にインスパイアされた新しいシステムを紹介する。モジュラー設計により個別化された投薬が可能になるが、薬物放出は各有効医薬品成分(API)の選択されたポリマーマトリックスに大きく依存する。
関連する概念動画
Brick Sizes
291
Brick sizing plays a crucial role in construction, influencing both the aesthetics and structural integrity of buildings. Bricks are defined by three dimensions: width, thickness, and length. They are commonly designed to fit modular measurements, typically in multiples of 4 inches or 8 inches in width, to facilitate uniform construction and compatibility with other building materials.
Modular bricks are the most common type and are sized to include the mortar joint, which is essential for...
Modular bricks are the most common type and are sized to include the mortar joint, which is essential for...
291
Antihypertensive Drugs: Types of β-Blockers
1.4K
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
1.4K
Hypertension IV: Drug Therapy and Lifestyle Modifications
610
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
610
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Antihypertensive Drugs: Action of β1 Blockers
1.9K
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
1.9K
Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.4K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.4K


